AI revolutionizes protein function prediction with “DeepGO-SE”

Researchers developed “DeepGO-SE,” a novel AI method for predicting protein functions from sequences, significantly outperforming traditional models by incorporating gene ontology and protein-protein interactions.

Shorla raises funds to advance oncology drug candidates

Shorla is involved in the development of treatments for oncology. Credit: Shorla Oncology. US-Ireland speciality pharmaceutical company Shorla Oncology has received $35m in Series B

October 5, 2023

Psychedelics: A new hope for substance abuse treatment

Study explores the history and current state of psychedelic research for treating substance abuse disorders, highlighting challenges like restrictive policies, lack of funding, and the

August 28, 2024

Updated: Lilly details mid-stage win for tirzepatide in MASH with fibrosis data

Eli Lilly has unveiled fibrosis results from a Phase 2 test of tirzepatide in patients with metabolic dysfunction-associated steatohepatitis, or MASH, which could help further

June 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.